Abstract 15913: Novel Dual MTOR Inhibitors/AMPK Activators Attenuate Doxorubicin-Induced Cardiotoxicity

2019 
Background: Doxorubicin (DOX) is among the most widely used and highly efficacious anticancer drugs for the treatment of breast cancer, however, its therapeutic application is limited by its life-t...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []